Skip to main content
. 2023 Mar 21;4(3):zqad011. doi: 10.1093/function/zqad011

Figure 1.

Figure 1.

Transcriptomic subtype classifications and surrogate markers of PDAC. Classical tumors are associated with a better patient survival with surrogate markers: GATA6, HNF1A/4A, and PDX. Basal-like tumors have poorer outcomes with surrogate markers: MYC, ΔNTP63, RUNX2, and KRT5/14/17. Hybrid tumors show a mixed character of classical and basal with high plasticity after drug treatment.